Sage Journals: Discover world-class research

Retricted access

Research article

First published 1994-12

An Intensive Treatment with Mitoxantrone and Ifosfamide in Second-Line Therapy of Epithelial Ovarian Cancer

Angelo Di Leo, Laura Biganzoli, Silvia Bohm [...]

Tumori Journal

Retricted access

Research article

First published 2015-3

Tivantinib,a New Option for Second-line Treatment of Advanced Hepatocellular Carcinoma? The Experience of Italian Centers

Lorenza Rimassa, Armando Santoro, Bruno Daniele [...]

Tumori Journal

Open access

Review article

First published 2023

Update on the second-line treatment of Helicobacter pylori infection: a narrative review

Chih-An Shih, Chang-Bih Shie, Wei-Chen Tai [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2023

Treatment Outcomes After Switching to Second-Line Anti-Retroviral Therapy: Results From the Thai National Treatment Program

Pupe Sudsila, Sirinya Teeraananchai, Sasisopin Kiertiburanakul [...]

Journal of the International Association of Providers of AIDS Care (JIAPAC)

Open access

Review article

First published 2021

Second-line treatment in renal cell carcinoma: clinical experience and decision making

Valentina Guadalupi, Giacomo Cartenì, Roberto Iacovelli [...]

Therapeutic Advances in Urology

Open access

Research article

First published 2020

Randomized controlled study on the effects of triple therapy including vonoprazan or rabeprazole for the second-line treatment of Helicobacter pylori infection

Mariko Hojo, Daisuke Asaoka, Tsutomu Takeda [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2021

Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol

Alessandro Ottaiano, Stefania Scala, Mariachiara Santorsola [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2019

A real-world analysis of second-line treatment options in pancreatic cancer: liposomal-irinotecan plus 5-fluorouracil and folinic acid

Markus Kieler, Matthias Unseld, Daniela Bianconi [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2020

Second-line treatment in patients with advanced extra-pulmonary poorly differentiated neuroendocrine carcinoma: a systematic review and meta-analysis

Mairéad G. McNamara, Melissa Frizziero, Timothy Jacobs [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2023

Cost-effectiveness analysis of axicabtagene ciloleucel as a second-line treatment for diffuse large B-cell lymphoma in China and the United States

Na Li, Jianying Lei, Jiahao Zhang [...]

Therapeutic Advances in Hematology

Search results